官方APP下载:英语全能特训(微信小程序版,支持苹果手机、安卓手机)
创办于2003年
UNSV记不住?那就记中文谐音“忧安思危”吧!
  Slow and Steady Wins the Race!
UNSV英语学习频道 - Slow and steady wins the race!
公众微信服务号
英语全能特训(微信公众服务号)
UNSV英语学习频道淘宝网店
客服短信:18913948480
客服邮箱:web@unsv.com
初级VIP会员
全站英语学习资料下载。
¥98元/12个月

HEALTH REPORT - New Malaria Drug Launched in Latin America, Southeast Asia

阅读次数:


VIP会员专享下载:(非VIP会员无权下载!如果想下载,但还不是VIP会员,请点此订购
下载方式:使用鼠标右键(注意是鼠标右键!)点击下面的MP3音频/MP4视频链接,然后选择“另存为…”。
MP3节目录音 MP3节目录音  PDF节目文稿 PDF节目文稿 
文章正文
同步字幕

This is the VOA Special English Health Report.

A Brazilian drug company and a nonprofit group have developed a new, simplified malaria treatment.

A laboratory worker shows reporters the new combination drug for malaria
A laboratory worker shows reporters the new combination drug for malaria

Patients have to take only one tablet a day for three days for some ages, or two tablets a day for three days for other ages.

The medicine combines two existing malaria drugs, artesunate and mefloquine. This combination has been widely used in recent years in Latin America and Southeast Asia.

The Brazilian government will make the new treatment available throughout Latin America and Southeast Asia over this year and next. The fixed-dose drug will be offered to public agencies at a target price of two and a half dollars for the full adult treatment.

Bernard Pecoul is head of the nonprofit group, called the Drugs for Neglected Diseases Initiative. He says the new formulation is safe and fast-acting, and effective for children and adults.

The World Health Organization says artemisinin-based combination treatments are the best way to treat common malaria. Research shows that the simpler the treatment, the more likely people are to complete it. People increase the risk of drug resistance when they do not complete a full treatment.

Researchers tested the new medicine in a one-year study of seventeen thousand patients in the state of Acre in the Brazilian Amazon. Health care resources in the area were also expanded, including early identification of malaria. Health officials say the result was a thirty-six percent drop in cases.

Malaria is caused by a parasite which is passed to humans though mosquito bites. As many as five hundred million infections happen every year. Around sixty percent of the cases, and more than eighty percent of the deaths, happen in Africa south of the Sahara. Africa suffers more than a million deaths, mostly children.

Doctor Pecoul says his organization is supporting a study in Tanzania to see if the new drug could be used successfully in Africa. Currently in Africa, there are two first-line treatments with artesunate and other drugs. He says artesunate and mefloquine could have a use in places like eastern Africa where there are high levels of resistance to several drugs.

The Drugs for Neglected Diseases Initiative began in two thousand three. It was established by the Pasteur Institute and Doctors Without Borders along with four publicly supported research organizations.

And that's the VOA Special English Health Report, written by Caty Weaver. For transcripts, MP3s and podcasts of our reports, go to www.unsv.com. I'm Steve Ember.

网友的学习评论(0条):
版权所有©2003-2019 南京通享科技有限公司,保留所有权利。未经书面许可,严禁转载本站内容,违者追究法律责任。 互联网经营ICP证:苏B2-20120186
网站备案:苏ICP备05000269号-1中国工业和信息化部网站备案查询
广播台